Tanaya Siripoon

Name: Tanaya Siripoon

ชื่อ-สกุล:  อาจารย์แพทย์หญิงธนยา ศิริปุณย์

Position: Lecturer

Department: Clinical Tropical Medicine

Tanaya.sir@mahidol.ac.th

Tanaya.sir@mahidol.edu

tanaya.toey@gmail.com

toeytutu@live.com



Last updated: March 7, 2022

Publication


2024

Khongsiri W, Poolchanuan P, Dulsuk A, Thippornchai N, Phunpang R, Runcharoen C, Boonprakob T, Hemtong O, Chowplijit S, Chuapaknam V, Siripoon T, Piyaphanee W, Luvira V, Rotejanaprasert C, Leaungwutiwong P, Chantratita W, Chantratita N, Kosoltanapiwat N. Associations between clinical data, vaccination status, antibody responses, and post-COVID-19 symptoms in Thais infected with SARS-CoV-2 Delta and Omicron variants: a 1-year follow-up study. BMC Infect Dis. 2024 Oct 7;24(1):1116. doi: 10.1186/s12879-024-09999-2.


Wongnak P, Schilling WHK, Jittamala P, Boyd S, Luvira V, Siripoon T, Ngamprasertchai T, Batty EM, Singh S, Kouhathong J, Pagornrat W, Khanthagan P, Hanboonkunupakarn B, Poovorawan K, Mayxay M, Chotivanich K, Imwong M, Pukrittayakamee S, Ashley EA, Dondorp AM, Day NPJ, Teixeira MM, Piyaphanee W, Phumratanaprapin W, White NJ, Watson JA; PLATCOV Collaborative Group. Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV). Lancet Infect Dis. 2024 Sep;24(9):953-963. doi: 10.1016/S1473-3099(24)00183-X.


Luvira V, Schilling WHK, Jittamala P, Watson JA, Boyd S, Siripoon T, Ngamprasertchai T, Almeida PJ, Ekkapongpisit M, Cruz C, Callery JJ, Singh S, Tuntipaiboontana R, Kruabkontho V, Ngernseng T, Tubprasert J, Abdad MY, Keayarsa S, Madmanee W, Aguiar RS, Santos FM, Hanboonkunupakarn P, Hanboonkunupakarn B, Poovorawan K, Imwong M, Taylor WRJ, Chotivanich V, Chotivanich K, Pukrittayakamee S, Dondorp AM, Day NPJ, Teixeira MM, Piyaphanee W, Phumratanaprapin W, White NJ; PLATCOV Collaborative Group. Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial. BMC Infect Dis. 2024 Jan 15;24(1):89. doi: 10.1186/s12879-023-08835-3.


2023

Jittamala P, Schilling WHK, Watson JA, Luvira V, Siripoon T, Ngamprasertchai T, Almeida PJ, Ekkapongpisit M, Cruz C, Callery JJ, Boyd S, Anunsittichai O, Hongsuwan M, Singhaboot Y, Pagornrat W, Tuntipaiboontana R, Kruabkontho V, Ngernseng T, Tubprasert J, Abdad MY, Keayarsa S, Madmanee W, Aguiar RS, Santos FM, Batty EM, Hanboonkunupakarn P, Hanboonkunupakarn B, Sookprome S, Poovorawan K, Imwong M, Taylor WRJ, Chotivanich V, Sangketchon C, Ruksakul W, Chotivanich K, Pukrittayakamee S, Dondorp AM, Day NPJ, Teixeira MM, Piyaphanee W, Phumratanaprapin W, White NJ; PLATCOV Collaborative Group. Clinical Antiviral Efficacy of Remdesivir in Coronavirus Disease 2019: An Open-Label, Randomized Controlled Adaptive Platform Trial (PLATCOV). J Infect Dis. 2023 Nov 11;228(10):1318-1325.


Schilling WHK, Jittamala P, Watson JA, Boyd S, Luvira V, Siripoon T, Ngamprasertchai T, Batty EM, Cruz C, Callery JJ, Singh S, Saroj M, Kruabkontho V, Ngernseng T, Tanglakmankhong N, Tubprasert J, Abdad MY, Madmanee W, Kouhathong J, Suwannasin K, Pagornrat W, Piaraksa N, Hanboonkunupakarn P, Hanboonkunupakarn B, Poovorawan K, Potaporn M, Srisubat A, Loharjun B, Taylor WRJ, Chotivanich V, Chotivanich K, Imwong M, Pukrittayakamee S, Dondorp AM, Day NPJ, Teixeira MM, Piyaphanee W, Phumratanaprapin W, White NJ; PLATCOV Collaborative Group. Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial. Lancet Infect Dis. 2023 Sep 28:S1473-3099(23)00493-0.


Siripoon T, Apiwattanakul N, Mongkolrattanakul P, Tongsook C, Unwanatham N, Hongeng S, Kantachuvesiri S, Bruminhent J. Clinical and immunological characteristics for BK polyomavirus-associated nephropathy after kidney transplantation. Immun Inflamm Dis. 2023 Aug;11(8):e956.


Schilling WHK, Jittamala P, Watson JA, Ekkapongpisit M, Siripoon T, Ngamprasertchai T, Luvira V, Pongwilai S, Cruz C, Callery JJ, Boyd S, Kruabkontho V, Ngernseng T, Tubprasert J, Abdad MY, Piaraksa N, Suwannasin K, Hanboonkunupakarn P, Hanboonkunupakarn B, Sookprome S, Poovorawan K, Thaipadungpanit J, Blacksell S, Imwong M, Tarning J, Taylor WRJ, Chotivanich V, Sangketchon C, Ruksakul W, Chotivanich K, Teixeira MM, Pukrittayakamee S, Dondorp AM, Day NPJ, Piyaphanee W, Phumratanaprapin W, White NJ; PLATCOV Collaborative Group. Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV). Elife. 2023 Feb 21;12:e83201.


Poolchanuan P, Matsee W, Sengyee S, Siripoon T, Dulsuk A, Phunpang R, Pisutsan P, Piyaphanee W, Luvira V, Chantratita N. Dynamics of Different Classes and Subclasses of Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Variants after Coronavirus Disease 2019 and CoronaVac Vaccination in Thailand. mSphere. 2023 Feb 21;8(1):e0046522.


2022

Srikirin P, Siripoon T, Charoenpong L, Soonthornworasiri N, Matsee W, Kittitrakul C, Tangkijvanich P, Charunwatthana P, Poovorawan K. Prevalence, Risk Factors, and Prognosis of Liver Involvement in Adult Patients with Chikungunya in Thailand. Am J Trop Med Hyg. 2022 Oct 17;107(5):1107-1113.


Luvira V, Siripoon T, Phiboonbanakit D, Somsri K, Watthanakulpanich D, Dekumyoy P. Strongyloides stercoralis: A Neglected but Fatal Parasite. Trop Med Infect Dis. 2022 Oct 17;7(10):310.


Onwan M, Matsee W, Lawpoolsri S, Pisutsan P, Siripoon T, Punrin S, Piyaphanee W. Temporal Trend of COVID-19 Vaccine Acceptance and Factors Influencing International Travellers. Trop Med Infect Dis. 2022 Sep 2;7(9):223.


Luvira V, Thippornchai N, Leaungwutiwong P, Siripoon T, Piroonamornpun P, Phumratanaprapin W, Iamsirithaworn S. Evidence of transmission of influenza A and influenza B co-infection in healthcare workers. J Infect Dev Ctries. 2022 Jul 28;16(7):1199-1205.


Ngamprasertchai T, Kajeekul R, Sivakorn C, Ruenroegnboon N, Luvira V, Siripoon T, Luangasanatip N. Efficacy and Safety of Immunomodulators in Patients with COVID-19: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. Infect Dis Ther. 2022 Feb;11(1):231-248.


2021

Sivakorn C, Dechsanga J, Jamjumrus L, Boonnak K, Schultz MJ, Dondorp AM, Phumratanaprapin W, Ratanarat R, Naorungroj T, Wattanawinitchai P, Siripoon T, Duangdee C, Techarang T. High Mobility Group Box 1 and Interleukin 6 at Intensive Care Unit Admission as Biomarkers in Critically Ill COVID-19 Patients. Am J Trop Med Hyg. 2021 July;105(1):73-80.


Clinical trial and publication experiences

2020 Principle investigator in “"Multiple opportunistic infections in adult-onset immunodeficiency associated with interferon-gamma autoantibody: A case report and literature review" (accepted manuscript)


2018 Principle investigator in “Correlation of BK Virus-specific Immunity and BK Viruria within 6 months after Kidney Transplantation: A Prospective Cohort Study” (data analysis)


Last updated: October 24, 2024